AL

Agran Libbie Portfolio holdings

AUM $425M
1-Year Est. Return 16.08%
This Quarter Est. Return
1 Year Est. Return
+16.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$425M
AUM Growth
+$12.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
133
New
Increased
Reduced
Closed

Top Buys

1
+$3.03M
2
+$1.28M
3
+$524K
4
AMLP icon
Alerian MLP ETF
AMLP
+$384K
5
VTR icon
Ventas
VTR
+$354K

Top Sells

1
+$3.18M
2
+$2.34M
3
+$1.69M
4
COP icon
ConocoPhillips
COP
+$889K
5
QCP
Quality Care Properties, Inc.
QCP
+$754K

Sector Composition

1 Financials 16.07%
2 Technology 16.01%
3 Energy 12.6%
4 Healthcare 11.25%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLS icon
101
Flowserve
FLS
$6.61B
$369K 0.09%
7,625
-3,570
PM icon
102
Philip Morris
PM
$246B
$369K 0.09%
3,266
-22
MIDD icon
103
Middleby
MIDD
$6.76B
$368K 0.09%
2,700
EOG icon
104
EOG Resources
EOG
$58B
$359K 0.08%
3,685
+1,050
TRP icon
105
TC Energy
TRP
$53.5B
$348K 0.08%
7,550
MO icon
106
Altria Group
MO
$109B
$314K 0.07%
4,392
-50
PFE icon
107
Pfizer
PFE
$139B
$314K 0.07%
+9,674
SLB icon
108
SLB Limited
SLB
$48.7B
$309K 0.07%
3,957
+700
JCI icon
109
Johnson Controls International
JCI
$71.2B
$307K 0.07%
7,297
-725
CRM icon
110
Salesforce
CRM
$231B
$303K 0.07%
3,675
-100
GD icon
111
General Dynamics
GD
$89.1B
$271K 0.06%
1,450
+100
NSC icon
112
Norfolk Southern
NSC
$65B
$253K 0.06%
2,260
-75
AGN
113
DELISTED
Allergan plc
AGN
$253K 0.06%
+1,060
IDXX icon
114
Idexx Laboratories
IDXX
$50.8B
$247K 0.06%
+1,600
MRVL icon
115
Marvell Technology
MRVL
$75.8B
$238K 0.06%
15,600
NVS icon
116
Novartis
NVS
$254B
$223K 0.05%
3,344
-83
OKE icon
117
Oneok
OKE
$42.9B
$213K 0.05%
+3,850
DUK icon
118
Duke Energy
DUK
$99.9B
$209K 0.05%
2,552
-83
ROP icon
119
Roper Technologies
ROP
$54.3B
$208K 0.05%
+1,005
ECL icon
120
Ecolab
ECL
$78.5B
$201K 0.05%
1,600
-207
CPRX icon
121
Catalyst Pharmaceutical
CPRX
$2.52B
$86K 0.02%
44,000
ARWR icon
122
Arrowhead Research
ARWR
$5.09B
$38K 0.01%
20,600
QLGN icon
123
Qualigen Therapeutics
QLGN
$7.4M
– –
0
MMLP icon
124
Martin Midstream Partners
MMLP
$97.6M
– –
-17,809
NVO icon
125
Novo Nordisk
NVO
$242B
– –
-12,900
2 3 4
5
6